![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/sadia.jpg?itok=Y97fbkwT&c=1469a91dfe921bb4e875663f09d80bd6)
Sadia L'Bouch
![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/heimendinger.jpg?itok=YWG6jppA&c=49e5253f484b1bca5ba4f4abec13e570)
Pierre Heimendinger
![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/20190903_kite_-15.jpg?itok=fqUiVXHn&c=1dc9d24c8122a88563da08d4b6bdc9a5)
Markwin Velders
![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/jean-pierre-latere-1-orig_1_orig.jpg?itok=lFn-8Bpn&c=05b8189f5cd43b07c0ef6743d85cd97c)
Jean-Pierre Latere Dwan’Isa
![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/jasmin_kee.jpg?itok=ThQD7xjg&c=294b9a6f2ad4a6ada27f79d28e7ff00d)
Jasmin Kee
![](https://edgeaisummit.com/sites/default/files/styles/panopoly_image_square/public/speakers/_mg_9997.jpg?itok=rsCzlgQp&c=0e8765b19f685a2a4adbefe682323ce0)
Dr. Machteld Tiemessen
In July 2018, Dr. Machteld Tiemessen joined Danone Nutricia Research as Team Leader Immunology in the Global Center of Excellence Immunology. Since obtaining her PhD in Immunology in 2004, which was focused on the induction of oral tolerance in food allergy, she has held many different positions, both at academia and in industry. The main topic at the start of her career was the investigation of the role and mechanisms of regulatory T cells in normal immune responses and during diseases, such as allergy and cutaneous T cell lymphoma. In 2010, she received a Veni-grant to further elucidate the role of Wnt-signaling in peripheral T cell function (not restricted to regulatory T cells). After 14 years of research at several universities in The Netherlands and King’s College in London, the United Kingdom, she started in 2013 at Johnson & Johnson to apply her immunological knowledge in the field of viral vaccines. At J&J, she led various discovery projects, with a focus on early discovery projects in the field of oncology vaccines and in the field of polio vaccines.